Sandesh Seth - Net Worth and Insider Trading
Sandesh Seth Net Worth
The estimated net worth of Sandesh Seth is at least $139,477 dollars as of 2024-05-23. Sandesh Seth is the Director of Relmada Therapeutics Inc and owns about 30,814 shares of Relmada Therapeutics Inc (RLMD) stock worth over $95,215. Sandesh Seth is also the Chairman & CEO of Actinium Pharmaceuticals Inc and owns about 5,111 shares of Actinium Pharmaceuticals Inc (ATNM) stock worth over $44,261. Details can be seen in Sandesh Seth's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sandesh Seth has not made any transactions after 2018-12-10 and currently still holds the listed stock(s).
Transaction Summary of Sandesh Seth
Sandesh Seth Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sandesh Seth owns 2 companies in total, including Actinium Pharmaceuticals Inc (ATNM) , and Relmada Therapeutics Inc (RLMD) .
Click here to see the complete history of Sandesh Seth’s form 4 insider trades.
Insider Ownership Summary of Sandesh Seth
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATNM | Actinium Pharmaceuticals Inc | 2018-12-10 | director |
| RLMD | Relmada Therapeutics Inc | 2015-12-15 | director |
Sandesh Seth Latest Holdings Summary
Sandesh Seth currently owns a total of 2 stocks. Among these stocks, Sandesh Seth owns 30,814 shares of Relmada Therapeutics Inc (RLMD) as of December 15, 2015, with a value of $95,215 and a weighting of 68.27%. Sandesh Seth also owns 5,111 shares of Actinium Pharmaceuticals Inc (ATNM) as of December 10, 2018, with a value of $44,261 and a weighting of 31.73%.
Latest Holdings of Sandesh Seth
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RLMD | Relmada Therapeutics Inc | 2015-12-15 | 30,814 | 3.09 | 95,215 |
| ATNM | Actinium Pharmaceuticals Inc | 2018-12-10 | 5,111 | 8.66 | 44,261 |
Holding Weightings of Sandesh Seth
Sandesh Seth Form 4 Trading Tracker
According to the SEC Form 4 filings, Sandesh Seth has made a total of 0 transactions in Relmada Therapeutics Inc (RLMD) over the past 5 years. The most-recent trade in Relmada Therapeutics Inc is the acquisition of 2,375 shares on December 15, 2015, which cost Sandesh Seth around $30,305.
According to the SEC Form 4 filings, Sandesh Seth has made a total of 0 transactions in Actinium Pharmaceuticals Inc (ATNM) over the past 5 years. The most-recent trade in Actinium Pharmaceuticals Inc is the acquisition of 333 shares on December 10, 2018, which cost Sandesh Seth around $4,400.
Insider Trading History of Sandesh Seth
- 1
Sandesh Seth Trading Performance
GuruFocus tracks the stock performance after each of Sandesh Seth's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sandesh Seth is 7.88%. GuruFocus also compares Sandesh Seth's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sandesh Seth within 3 months outperforms 4 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sandesh Seth's insider trading performs compared to the benchmark.
Performance of Sandesh Seth
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.2 | | | | | |
| Relative Return to S&P 500(%) | -8.1 | | | | | |
Sandesh Seth Ownership Network
Sandesh Seth Owned Company Details
What does Actinium Pharmaceuticals Inc do?
Who are the key executives at Actinium Pharmaceuticals Inc?
Sandesh Seth is the director of Actinium Pharmaceuticals Inc. Other key executives at Actinium Pharmaceuticals Inc include VP & Finance and Corporate Dev. Steve O'loughlin , Chief Scientific Officer Dale L. Ludwig , and Chief Commercial Officer Anil Kapur .
Actinium Pharmaceuticals Inc (ATNM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Actinium Pharmaceuticals Inc (ATNM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Actinium Pharmaceuticals Inc (ATNM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Actinium Pharmaceuticals Inc (ATNM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Actinium Pharmaceuticals Inc Insider Transactions
Sandesh Seth Mailing Address
Above is the net worth, insider trading, and ownership report for Sandesh Seth. You might contact Sandesh Seth via mailing address: 300 E 93rd Street, #20-b, New York Ny 10128.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
